Limflow Appoints Mike Mathias as Vice President, Commercial Operations

LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), today announced

Related Keywords

Japan ,United States ,Canada ,France ,French ,Michelle Mcadam ,Dan Rose ,Kostenloser Wertpapierhandel ,Theo Mastrokostopoulos ,Market Development ,Chronic Communications Inc ,Pfizer ,University Of Minnesota ,Business Administration ,Medtronic ,Us Military Academy At West Point ,Mike Mathias ,Vice President ,Medtronic Structural Heart ,French Studies ,West Point ,Limflow System ,Global Sales ,General Manager ,Chronic Limb Threatening Ischemia ,Chronic Communications ,Limflow ,Ppoints ,Bike ,Imathias ,Ice ,President ,Commercial ,Operations ,